Renal  ||| S:0 E:6 ||| JJ
osteodystrophy  ||| S:6 E:21 ||| NN
and  ||| S:21 E:25 ||| CC
vascular  ||| S:25 E:34 ||| FW
calcification  ||| S:34 E:48 ||| FW
Chronic  ||| S:48 E:56 ||| FW
kidney  ||| S:56 E:63 ||| FW
disease  ||| S:63 E:71 ||| FW
( ||| S:71 E:72 ||| -LRB-
CKD ||| S:72 E:75 ||| NNP
)  ||| S:75 E:77 ||| -RRB-
is  ||| S:77 E:80 ||| VBZ
characterized  ||| S:80 E:94 ||| VBN
by  ||| S:94 E:97 ||| IN
phosphate  ||| S:97 E:107 ||| JJ
retention  ||| S:107 E:117 ||| NN
and  ||| S:117 E:121 ||| CC
reduced  ||| S:121 E:129 ||| JJ
synthesis  ||| S:129 E:139 ||| NN
of  ||| S:139 E:142 ||| IN
1.25 ||| S:142 E:146 ||| CD
( ||| S:146 E:147 ||| -LRB-
OH ||| S:147 E:149 ||| NNP
) ||| S:149 E:150 ||| -RRB-
2-vitamin  ||| S:150 E:160 ||| NNP
D  ||| S:160 E:162 ||| NNP
stimulating  ||| S:162 E:174 ||| FW
parathyroid  ||| S:174 E:186 ||| FW
hyperplasia ||| S:186 E:197 ||| FW
.  ||| S:197 E:199 ||| .
These  ||| S:199 E:205 ||| DT
changes  ||| S:205 E:213 ||| NNS
cause  ||| S:213 E:219 ||| VBP
a  ||| S:219 E:221 ||| DT
complex  ||| S:221 E:229 ||| JJ
osteopathy ||| S:229 E:239 ||| NN
,  ||| S:239 E:241 ||| ,
defined  ||| S:241 E:249 ||| VBN
as  ||| S:249 E:252 ||| IN
renal  ||| S:252 E:258 ||| JJ
osteodystrophy ||| S:258 E:272 ||| NN
,  ||| S:272 E:274 ||| ,
and  ||| S:274 E:278 ||| CC
vascular  ||| S:278 E:287 ||| JJ
calcification ||| S:287 E:300 ||| NN
.  ||| S:300 E:302 ||| .
Renal  ||| S:302 E:308 ||| JJ
osteodystrophy  ||| S:308 E:323 ||| NN
increases  ||| S:323 E:333 ||| VBZ
the  ||| S:333 E:337 ||| DT
risk  ||| S:337 E:342 ||| NN
of  ||| S:342 E:345 ||| IN
fracture  ||| S:345 E:354 ||| NN
and  ||| S:354 E:358 ||| CC
causes  ||| S:358 E:365 ||| VBZ
deformities  ||| S:365 E:377 ||| VBN
and  ||| S:377 E:381 ||| CC
disability ||| S:381 E:391 ||| NN
.  ||| S:391 E:393 ||| .
Vascular  ||| S:393 E:402 ||| JJ
calcification  ||| S:402 E:416 ||| NN
occurs  ||| S:416 E:423 ||| VBZ
in  ||| S:423 E:426 ||| IN
a  ||| S:426 E:428 ||| DT
large  ||| S:428 E:434 ||| JJ
proportion  ||| S:434 E:445 ||| NN
of  ||| S:445 E:448 ||| IN
hemodialysis  ||| S:448 E:461 ||| JJ
patients  ||| S:461 E:470 ||| NNS
and  ||| S:470 E:474 ||| CC
is  ||| S:474 E:477 ||| VBZ
a  ||| S:477 E:479 ||| DT
marker  ||| S:479 E:486 ||| NN
of  ||| S:486 E:489 ||| IN
arteriopathy ||| S:489 E:501 ||| NN
.  ||| S:501 E:503 ||| .
Calcifying  ||| S:503 E:514 ||| FW
arteriopathy  ||| S:514 E:527 ||| FW
induces  ||| S:527 E:535 ||| FW
arterial  ||| S:535 E:544 ||| FW
stiffness  ||| S:544 E:554 ||| FW
and  ||| S:554 E:558 ||| CC
contributes  ||| S:558 E:570 ||| VBZ
to  ||| S:570 E:573 ||| TO
the  ||| S:573 E:577 ||| DT
high  ||| S:577 E:582 ||| JJ
cardiovascular  ||| S:582 E:597 ||| JJ
mortality  ||| S:597 E:607 ||| NN
and  ||| S:607 E:611 ||| CC
morbidity  ||| S:611 E:621 ||| NN
among  ||| S:621 E:627 ||| IN
CKD  ||| S:627 E:631 ||| NNP
patients ||| S:631 E:639 ||| NNS
.  ||| S:639 E:641 ||| .
Vascular  ||| S:641 E:650 ||| JJ
calcification  ||| S:650 E:664 ||| JJ
results  ||| S:664 E:672 ||| NNS
from  ||| S:672 E:677 ||| IN
a  ||| S:677 E:679 ||| DT
process  ||| S:679 E:687 ||| NN
of  ||| S:687 E:690 ||| IN
local  ||| S:690 E:696 ||| JJ
bone  ||| S:696 E:701 ||| NN
formation  ||| S:701 E:711 ||| NN
induced  ||| S:711 E:719 ||| NN
by  ||| S:719 E:722 ||| IN
osteoblast-like  ||| S:722 E:738 ||| JJ
cells  ||| S:738 E:744 ||| NNS
developing  ||| S:744 E:755 ||| VBG
in  ||| S:755 E:758 ||| IN
the  ||| S:758 E:762 ||| DT
vascular  ||| S:762 E:771 ||| JJ
wall  ||| S:771 E:776 ||| NN
from  ||| S:776 E:781 ||| IN
resident  ||| S:781 E:790 ||| JJ
cells ||| S:790 E:795 ||| NNS
.  ||| S:795 E:797 ||| .
Osteoblast  ||| S:797 E:808 ||| JJ
differentiation  ||| S:808 E:824 ||| NN
of  ||| S:824 E:827 ||| IN
resident  ||| S:827 E:836 ||| JJ
vascular  ||| S:836 E:845 ||| JJ
cells  ||| S:845 E:851 ||| NNS
may  ||| S:851 E:855 ||| MD
be  ||| S:855 E:858 ||| VB
mediated  ||| S:858 E:867 ||| VBN
by  ||| S:867 E:870 ||| IN
metabolic  ||| S:870 E:880 ||| JJ
factors  ||| S:880 E:888 ||| NNS
and  ||| S:888 E:892 ||| CC
may  ||| S:892 E:896 ||| MD
be  ||| S:896 E:899 ||| VB
induced  ||| S:899 E:907 ||| VBN
by  ||| S:907 E:910 ||| IN
high  ||| S:910 E:915 ||| JJ
concentrations  ||| S:915 E:930 ||| NNS
of  ||| S:930 E:933 ||| IN
phosphate ||| S:933 E:942 ||| NN
.  ||| S:942 E:944 ||| .
Therefore ||| S:944 E:953 ||| RB
,  ||| S:953 E:955 ||| ,
phosphate  ||| S:955 E:965 ||| JJ
retention  ||| S:965 E:975 ||| NN
appears  ||| S:975 E:983 ||| VBZ
as  ||| S:983 E:986 ||| IN
the  ||| S:986 E:990 ||| DT
most  ||| S:990 E:995 ||| RBS
detrimental  ||| S:995 E:1007 ||| JJ
factor  ||| S:1007 E:1014 ||| NN
affecting  ||| S:1014 E:1024 ||| VBG
arteries  ||| S:1024 E:1033 ||| NNS
in  ||| S:1033 E:1036 ||| IN
CKD  ||| S:1036 E:1040 ||| NNP
patients ||| S:1040 E:1048 ||| NNS
.  ||| S:1048 E:1050 ||| .
There  ||| S:1050 E:1056 ||| EX
is  ||| S:1056 E:1059 ||| VBZ
no  ||| S:1059 E:1062 ||| DT
specific  ||| S:1062 E:1071 ||| JJ
therapy  ||| S:1071 E:1079 ||| NN
to  ||| S:1079 E:1082 ||| TO
revert  ||| S:1082 E:1089 ||| VB
soft  ||| S:1089 E:1094 ||| JJ
tissue  ||| S:1094 E:1101 ||| NN
calcification ||| S:1101 E:1114 ||| NN
,  ||| S:1114 E:1116 ||| ,
but  ||| S:1116 E:1120 ||| CC
calcification  ||| S:1120 E:1134 ||| NNS
must  ||| S:1134 E:1139 ||| MD
be  ||| S:1139 E:1142 ||| VB
prevented  ||| S:1142 E:1152 ||| VBN
in  ||| S:1152 E:1155 ||| IN
the  ||| S:1155 E:1159 ||| DT
early  ||| S:1159 E:1165 ||| JJ
stages  ||| S:1165 E:1172 ||| NNS
of  ||| S:1172 E:1175 ||| IN
CKD ||| S:1175 E:1178 ||| NNP
.  ||| S:1178 E:1180 ||| .
